http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2128339-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b80b87728269f74bfc2bc3cff4523af http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_814cb499316f5dd84b8c1d8bae54d2c8 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-52 |
| filingDate | 1997-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1999-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81b8fff30f9b692799be5c3063226865 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7187d00640eb6fc7229a281d5ffd67c3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b400cef84be10799949c70841a73bcd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c15fc79f62a66644d94c97bfa2bf91a9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd17f5009f61f5419694916d670c83bb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_968cbc4e96b769bab02c7df48fa2f235 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c69e3e663c6089d8f1b46f29b6feadf9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdbb1415370ed690f1da8a44e1824dbd |
| publicationDate | 1999-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2128339-C1 |
| titleOfInvention | Method of determining cyclosporin a in blood |
| abstract | FIELD: hematology. SUBSTANCE: capillary blood sample (0.1-0.3 ml) is placed on chromatographic paper, dried at 15-35 C for 1.5-2 hr, diluted with 8- 12 ml of distilled water, treated with reagents, extracted with 80-100 ml of methanol, centrifuged, and subjected to spectrophotometric analysis to plot calibration curve, from which cyclosporin A level in blood is determined. One advantage of the invention is possibility to store blood sample on chromatographic paper for a long time and also to transport it from remote populated areas. Subsequent treatment of preserved blood according to above-indicated procedure, independently of the time of its arrival into laboratory, makes its possible to obtain reliably accurate results concerning immunosuppressive capacity of patient. EFFECT: facilitated reliable analysis. 1 dwg, 2 ex |
| priorityDate | 1997-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.